Verona Pharma Plc (VRNA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
RA Capital Management

Peter Kolchinsky

7,632,646 $110,368,061 +21% 1.45%
2. 4,000,000 $57,840,000 +26% 1.72%
3.
Vivo Capital

Albert Cha And Frank Kung

3,549,758 $51,329,501 -2% 4.74%
4.
Maverick Capital

Lee Ainslie

3,092,807 $44,721,989 +75% 0.84%
5.
OrbiMed Advisors

Samuel Isaly

2,861,801 $41,381,642 -16% 0.81%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.87 36,000 Director 880,643 2024-08-12 Filing
$1.84 33,736 Director 144,800 2023-11-20 Filing
$1.98 160,000 Director 844,643 2023-11-06 Filing
$1.31 4,800,000 Large Shareholder 55,911,648 2022-08-15 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.38 3,200 Officer 13,669,360 2024-10-25 Filing
$4.38 141,360 Officer 13,672,560 2024-10-24 Filing
$4.38 4,800 Officer, Director 14,591,736 2024-10-25 Filing
$4.38 140,000 Officer, Director 14,596,536 2024-10-24 Filing
$4.38 16 Officer, Director 14,736,536 2024-10-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 5,108,563 $111,024,890 7.39%
2. 4,902,377 $97,459,255 0%
3. 3,783,994 $75,225,800 0.01%
4. 3,014,349 $59,925,258 3.2%
5. 2,493,530 $49,571,376 0.12%
News See All